SAMN03167713
External Id
dbGaP
INSDC center name
2014-11-07T00:25:43.350Z
INSDC first public
2024-04-22T20:20:59.090Z
INSDC last update
live
INSDC status
Generic
NCBI submission model
Generic.1.0
NCBI submission package
ERS19221915
SRA accession
RNA
analyte type
NCI_AdjuvantTrastuzumab_NSABP_B31
biospecimen repository
959
biospecimen repository sample id
breast
http://purl.obolibrary.org/obo/UBERON_0000310
body site
phs000826
gap_accession
1
gap_consent_code
DS-CA-IRB-MDS
gap_consent_short_name
1426548
gap_sample_id
1093755
gap_subject_id
Ductal Adenocarcinoma
histological type
Yes
is tumor
miRNA Expression (Array)
molecular data type
Homo sapiens
http://purl.obolibrary.org/obo/NCBITaxon_9606
organism
Clinical Trial
study design
Prediction of Trastuzumab Benefit in Adjuvant Breast Cancer: NSABP B31
study name
959
submitted sample id
959
submitted subject id
NCI_AdjuvantTrastuzumab_NSABP_B31
submitter handle
Tumor RNA sample from breast of a human participant in the dbGaP study Prediction of Trastuzumab Benefit in Adjuvant Breast Cancer: NSABP B31
title